info icon

Other congenital malformations of eye

Q17_OTHER_CONGEN_MALFO_EYE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q15
  • Cause of death: ICD-10 Q15

2 out of 7 registries used, show all original rules.

49

4. Check minimum number of events

None

49

5. Include endpoints

49

6. Filter based on genotype QC (FinnGen only)

44

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q1
Name in latin
Aliae malformationes congenitae oculi

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 525 234 288
Only index persons 427 193 234
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 18.66 28.71 9.93
Only index persons 23.10 30.94 16.64

-FinnGen-

Key figures

All Female Male
Number of individuals 44 25 19
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 46.28 45.13 47.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
242
2.56
2.28
3.7
3.5
—
—
—
0
0
44
352
3.44
2.22
18.0
20.3
13.55
14.30
%
1.76
44
344
13
57
2.74
2.20
1.9
2.2
—
—
—
0
0
21
117
2.39
2.20
4.2
6.8
—
—
—
0
0
49
441
+∞
1.81
21.3
22.9
245.90
253.04
e9/l
0.31
49
428
49
441
+∞
1.81
21.3
23.0
6.63
6.85
e9/l
0.28
49
425
49
441
+∞
1.81
21.4
23.0
131.27
132.73
g/l
0.30
49
432
17
99
2.10
1.52
7.8
3.1
7.39
7.41
ph
—
5
23
20
127
1.97
1.41
5.4
3.1
—
—
—
0
0
23
155
1.91
1.36
6.1
4.0
9.67
73.37
e6/l
1.71
18
110
20
131
1.89
1.27
2.0
1.8
77.20
91.63
pmol/l
—
10
64
20
133
1.85
1.20
1.6
2.0
—
—
—
0
0
18
119
1.81
1.08
2.8
2.5
—
—
—
0
0
24
176
1.71
1.00
8.4
10.8
1.24
1.22
mmol/l
0.69
24
168
11
63
1.96
1.00
2.0
2.2
—
—
—
0
0
44
393
2.17
0.90
16.2
18.2
139.61
139.54
mmol/l
0.07
44
382
44
395
2.11
0.90
16.5
18.2
3.98
3.99
mmol/l
0.07
44
382
15
99
1.74
0.89
3.9
3.3
—
—
—
0
0
35
290
1.72
0.89
6.4
7.4
89.77
93.03
u/l
0.11
35
276
13
84
1.75
0.82
2.8
2.0
1.23
1.30
mmol/l
0.20
13
70
0
24
0.00
0.81
0.0
8.6
—
—
—
0
0
7
39
1.92
0.76
1.0
1.3
—
—
—
0
0
17
121
1.62
0.76
3.0
5.0
—
—
—
0
0
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
31
262
1.50
0.61
5.4
4.3
—
—
—
0
0
9
61
1.58
0.58
1.8
1.8
1397.22
1228.39
nmol/l
—
9
51
13
92
1.56
0.58
1.5
4.9
—
—
—
0
0
6
38
1.66
0.56
1.0
1.3
—
—
—
0
0
14
102
1.52
0.55
1.6
1.6
—
—
—
0
0
8
117
0.62
0.54
3.6
2.8
—
—
—
0
0
25
207
1.42
0.52
7.2
8.7
—
—
—
0
0
0
15
0.00
0.42
0.0
3.2
—
336.33
—
0
15
0
15
0.00
0.42
0.0
1.4
—
1.12
—
0
15
0
15
0.00
0.42
0.0
3.3
—
—
—
0
0
24
204
1.35
0.40
6.0
7.9
4.04
3.01
%
1.29
24
190
21
175
1.35
0.39
3.4
2.8
124.01
86.57
ug/l
0.38
21
167
24
205
1.33
0.38
7.1
7.7
52.50
53.21
%
0.08
24
195
24
205
1.33
0.38
6.0
8.0
9.14
8.44
%
0.58
24
194
6
87
0.65
0.37
1.3
4.5
318.67
343.51
umol/l
—
6
72
6
46
1.35
0.34
1.2
1.2
—
—
—
0
0
38
351
1.37
0.32
4.3
4.4
1.73
1.98
mu/l
0.90
38
315
12
94
1.37
0.32
3.6
4.8
1.24
2.17
ug/l
0.75
12
79
24
209
1.29
0.32
6.0
7.9
30.02
30.86
%
0.09
24
199
7
55
1.32
0.31
1.4
1.2
—
—
—
0
0
7
55
1.32
0.31
4.1
2.3
24.71
25.67
%
—
7
50
36
332
1.32
0.29
4.4
4.1
1.41
1.45
mmol/l
0.24
36
298
23
201
1.27
0.29
6.3
7.9
0.80
0.66
%
0.94
23
190
9
73
1.28
0.27
2.2
1.7
—
—
—
0
0
10
78
1.35
0.27
1.4
1.4
29.93
21.90
nmol/l
—
10
63
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
6
47
1.31
0.21
2.2
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
4.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
3.3
—
3.82
—
0
12
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
0.25
—
0
14
0
14
0.00
0.20
0.0
3.4
—
3.71
—
0
14
7
60
1.19
0.19
2.1
1.4
—
—
—
0
0
14
121
1.22
0.17
1.9
3.5
—
—
—
0
0
8
71
1.15
0.17
5.0
9.7
0.70
0.82
mmol/l
—
8
66
8
71
1.15
0.17
2.3
1.7
—
—
—
0
0
6
77
0.75
0.17
1.7
1.7
469.00
519.06
pmol/l
—
6
68
18
161
1.19
0.16
16.2
14.8
1.20
1.22
inr
—
10
50
36
342
1.20
0.15
5.1
4.5
2.60
2.66
mmol/l
0.17
36
310
35
334
1.17
0.12
4.7
4.3
5.64
5.80
mmol/l
0.67
35
302
21
194
1.14
0.11
5.4
8.4
23.48
19.47
umol/l
0.13
21
185
5
46
1.10
0.10
1.8
9.2
22.60
22.93
mmol/l
—
5
46
6
54
1.13
0.09
1.5
5.2
1.60
1.61
%
—
6
49
5
59
0.83
0.09
1.0
2.0
97.80
125.58
ug/g
—
5
45
8
76
1.06
0.08
11.3
9.1
1.06
1.24
mmol/l
—
8
70
31
321
0.91
0.06
4.9
5.4
37.27
39.31
mmol/mol
1.03
31
296
11
100
1.13
0.06
5.9
3.0
—
—
—
0
0
10
106
0.93
0.01
3.7
3.1
71.20
55.13
u/l
—
10
99
33
324
1.06
0.01
3.7
3.8
1.11
1.17
mmol/l
0.32
33
289
15
145
1.05
0.00
2.9
3.5
32.89
43.43
ng/l
—
9
104
29
292
0.98
0.00
4.2
3.8
14.69
14.70
pmol/l
0.00
29
269
5
58
0.85
0.00
7.0
8.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
58
1.04
-0.00
8.5
16.5
25.17
24.69
mmol/l
—
6
58
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
3.01
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
139.83
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
23.58
—
0
6
5
55
0.90
-0.00
7.2
11.0
102.40
104.49
mmol/l
—
5
55
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
1.43
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
12.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
88.67
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
166.33
—
0
9
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.9
—
6.44
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
11.50
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.3
—
7.65
—
0
8
0
5
0.00
-0.00
0.0
3.0
—
0.37
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
148.40
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
1.47
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
1685.48
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
1739.17
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_EYE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_EYE.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: Q17_OTHER_CONGEN_MALFO_EYE – Other congenital malformations of eye

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data